Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets – a SwissDiab study - Report - MDSpire
Advertisement
Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets – a SwissDiab study
Clinical Report: Lipid Management Targets in Type 1 Diabetes Mellitus Patients
Overview
The SwissDiab study evaluated lipid management in type 1 diabetes mellitus (T1DM) patients, revealing low attainment rates for LDL-C, non-HDL-C, and apoB targets. Only 11.6% of patients achieved LDL-C targets, while 30.6% and 59.7% reached non-HDL-C and apoB targets, respectively.
Background
Type 1 diabetes mellitus (T1DM) is associated with a significantly increased risk of atherosclerotic cardiovascular disease (ASCVD), which is often underestimated in clinical practice. Effective lipid management is crucial for reducing cardiovascular risk in this population, as traditional risk factors may not fully capture the increased ASCVD risk. Current guidelines recommend monitoring and targeting specific lipid biomarkers to improve patient outcomes.
Data Highlights
Parameter
Target Attainment (%)
LDL-C
11.6
Non-HDL-C
30.6
ApoB
59.7
All three targets
11.1
No targets
39.8
Key Findings
Median age of participants was 43.6 years with a diabetes duration of 16 years.
33.6% of patients were prescribed lipid-lowering therapy.
Only 11.6% of patients achieved the LDL-C target as per guidelines.
30.6% reached the non-HDL-C target, and 59.7% achieved the apoB target.
39.8% of patients did not meet any of the lipid targets.
There is a need for increased awareness regarding lipid management in T1DM.
Clinical Implications
The findings highlight the need for improved lipid management strategies in T1DM patients to meet current guidelines. Clinicians should consider regular monitoring of lipid levels and the potential need for lipid-lowering therapy to reduce cardiovascular risk.
Conclusion
The study underscores the importance of addressing lipid management in T1DM, revealing significant gaps in target attainment that could impact cardiovascular risk prevention efforts.
